JUN 03, 2021 7:30 AM PDT

Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters

WRITTEN BY: Tara Fernandez

Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper to produce. Researchers have shown for the first time that inhalable nanobodies against SARS-CoV-2 can prevent and treat severe COVID in a hamster model of the disease.

The immune systems of camels, dromedaries, llamas, and alpacas feature this unique miniature antibody, which has been of particular interest to researchers for their application as therapeutic biologics. While most antibodies have both heavy and light chains, nanobodies have only heavy chains, making them around a tenth of the size of a monoclonal antibody.

In the study, small inhaled doses of the experimental nanobody treatment called Nanobody-21, or PiN-21, neutralized the coronavirus in infected animals, reducing the number of infectious viral particles in their respiratory tracts by a million-fold. Additionally, breathing in PiN-21 also had a protective effect when the hamsters were administered the treatment at the time of the infection. Even ultra-low doses of the nanobody were found to be effective, shielding the animals against inflammation and damage to their respiratory tracts.

“Inhalation treatment quickly reverses animals’ weight loss after infection, decreases lung viral titers by 6 logs leading to drastically mitigated lung pathology, and prevents viral pneumonia,” wrote the authors.

Senior author of the study, Yi Shi said: “By using an inhalation therapy that can be directly administered to the infection site—the respiratory tract and lungs—we can make treatments more efficient.” 

“We are very excited and encouraged by our data suggesting that PiN-21 can be highly protective against severe disease and can potentially prevent human-to-human viral transmission.”

The physical characteristics of nanobodies make them particularly well suited to be delivered as aerosols—tiny particles that when breathed in, reach deep into the intricate lung structures. With their dual function as both a treatment and a prophylactic, nanobodies may represent an urgently-needed complementary approach to vaccination.

The research team, which consists of nanobody, infectious disease, and aerobiology experts, is continuing to explore PiN-21 as a potential clinical drug candidate.

 


Sources: University of Pittsburgh, Science Advances.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 31, 2021
Clinical & Molecular DX
Five Questions to Help You Select the Best Cellular Stain
AUG 31, 2021
Five Questions to Help You Select the Best Cellular Stain
Cellular stains are organic fluorescent dyes or fluorescent conjugates designed to localize to a specific organelle or c ...
SEP 14, 2021
Drug Discovery & Development
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
SEP 14, 2021
A novel drug that targets the removal of pathogenic antibodies in myasthenia gravis
Myasthenia gravis is a chronic autoimmune disorder characterized by muscle weakness and fatigue. The disorder leads to a ...
SEP 28, 2021
Immunology
Caught on Tape: Immune Cells Migrating From the Gut to the Brain
SEP 28, 2021
Caught on Tape: Immune Cells Migrating From the Gut to the Brain
A team of immunologists has taken the first glimpse at a never-before-seen migratory path of immune cells from the gut a ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
NOV 08, 2021
Cell & Molecular Biology
Understanding How Problems in Bone Marrow Transplants Arise
NOV 08, 2021
Understanding How Problems in Bone Marrow Transplants Arise
The hematopoietic system is how new blood cells are formed; hematopoietic stem cells in bone marrow generate new hematop ...
DEC 02, 2021
Microbiology
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
DEC 02, 2021
A 'Bispecific Antibody' to Fight Crimean-Congo Hemorrhagic Fever
Crimean-Congo hemorrhagic fever (CCHF) is a deadly disease, which is fatal in about 30 percent of cases. It's caused ...
Loading Comments...